Study Protocol: Development and Retrospective Validation of an Artificial Intelligence System for Diagnostic Assessment of Prostate Biopsies
Nita Mulliqi, Anders Blilie, Xiaoyi Ji, Kelvin Szolnoky, Henrik Olsson, Matteo Titus, Geraldine Martinez Gonzalez, Sol Erika Boman, Masi Valkonen, Einar Gudlaugsson, Svein R Kjosavik, Jose Asenjo, Marcello Gambacorta, Paolo Libretti, Marcin Braun, Radzislaw Kordek, Roman Lowicki, View ORCID ProfileKristina Hotakainen, Paivi Vare, Bodil Ginnerup Pedersen, Karina Dalsgaard Sorensen, Benedicte Parm Ulhoi, Mattias Rantalainen, Pekka Ruusuvuori, Brett Delahunt, Hemamali Samaratunga, Toyonori Tsuzuki, Emilius A.M. Janssen, View ORCID ProfileLars Egevad, View ORCID ProfileKimmo Kartasalo, View ORCID ProfileMartin Eklund
doi: https://doi.org/10.1101/2024.07.04.24309948
Nita Mulliqi
1 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden;
Anders Blilie
2 Department of Pathology, Stavanger University Hospital, Stavanger, Norway & Faculty of Health Sciences, University of Stavanger, Stavanger, Norway;
Xiaoyi Ji
1 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden;
Kelvin Szolnoky
1 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden;
Henrik Olsson
1 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden;
Matteo Titus
1 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden;
Geraldine Martinez Gonzalez
1 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden;
Sol Erika Boman
3 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden & Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden;
Masi Valkonen
4 Institute of Biomedicine, University of Turku, Turku, Finland;
Einar Gudlaugsson
5 Department of Pathology, Stavanger University Hospital, Stavanger, Norway;
Svein R Kjosavik
6 Faculty of Health Sciences, University of Stavanger, Stavanger, Norway & The General Practice and Care Coordination Research Group, Stavanger University Hospital, Norway;
Jose Asenjo
7 Department of Pathology, Synlab, Madrid, Spain;
Marcello Gambacorta
8 Department of Pathology, Synlab, Brescia, Italy;
Paolo Libretti
8 Department of Pathology, Synlab, Brescia, Italy;
Marcin Braun
9 Department of Pathology, Chair of Oncology, Medical University of Lodz, Lodz, Poland;
Radzislaw Kordek
9 Department of Pathology, Chair of Oncology, Medical University of Lodz, Lodz, Poland;
Roman Lowicki
10 1st Department of Urology, Medical University of Lodz, Lodz, Poland;
Kristina Hotakainen
11 Department of Clinical Chemistry, University of Helsinki, Helsinki, Finland & Laboratory Services, Mehilainen Oy, Helsinki, Finland;
Paivi Vare
12 Mehilainen Lansi-Pohja Hospital, Kemi, Finland;
Bodil Ginnerup Pedersen
13 Department of Radiology, Aarhus University Hospital, Aarhus, Denmark & Department of Clinical Medicine, Aarhus University, Aarhus, Denmark;
Karina Dalsgaard Sorensen
14 Department of Clinical Medicine, Aarhus University, Aarhus, Denmark & Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark;
Benedicte Parm Ulhoi
15 Department of Pathology, Aarhus University Hospital, Aarhus, Denmark;
Mattias Rantalainen
1 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden;
Pekka Ruusuvuori
16 Institute of Biomedicine, University of Turku, Turku, Finland & Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland;
Brett Delahunt
17 Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand;
Hemamali Samaratunga
18 Aquesta Uropathology and University of Queensland, QLD, Brisbane, Australia;
Toyonori Tsuzuki
19 Department of Surgical Pathology, School of Medicine, Aichi Medical University, Nagoya, Japan;
Emilius A.M. Janssen
20 Department of Pathology, Stavanger University Hospital, Stavanger, Norway & Faculty of Science and Technology, University of Stavanger, Stavanger, Norway;
Lars Egevad
21 Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden
Kimmo Kartasalo
1 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden;
Martin Eklund
1 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden;
Data Availability
A subset of the data used for model training (STHLM3 and RUMC cohorts) are available for non-commercial purposes subject to a CC BY-SA-NC 4.0 license as part of the PANDA challenge dataset and are freely downloadable after registration at https://www.kaggle.com/c/prostate-cancer-grade-assessment. The validation cohort SPROB20 is available for non-commercial purposes under the AIDA BY license upon accepted access request at the AIDA Data Hub at https://datahub.aida.scilifelab.se/10.23698/aida/sprob20. The validation cohorts UKK and WNS are available for non-commercial purposes under the CC BY-NC-SA 4.0 license upon accepted access request at https://zenodo.org/records/8102833 and https://zenodo.org/records/8102929.
Posted July 07, 2024.
Study Protocol: Development and Retrospective Validation of an Artificial Intelligence System for Diagnostic Assessment of Prostate Biopsies
Nita Mulliqi, Anders Blilie, Xiaoyi Ji, Kelvin Szolnoky, Henrik Olsson, Matteo Titus, Geraldine Martinez Gonzalez, Sol Erika Boman, Masi Valkonen, Einar Gudlaugsson, Svein R Kjosavik, Jose Asenjo, Marcello Gambacorta, Paolo Libretti, Marcin Braun, Radzislaw Kordek, Roman Lowicki, Kristina Hotakainen, Paivi Vare, Bodil Ginnerup Pedersen, Karina Dalsgaard Sorensen, Benedicte Parm Ulhoi, Mattias Rantalainen, Pekka Ruusuvuori, Brett Delahunt, Hemamali Samaratunga, Toyonori Tsuzuki, Emilius A.M. Janssen, Lars Egevad, Kimmo Kartasalo, Martin Eklund
medRxiv 2024.07.04.24309948; doi: https://doi.org/10.1101/2024.07.04.24309948
Study Protocol: Development and Retrospective Validation of an Artificial Intelligence System for Diagnostic Assessment of Prostate Biopsies
Nita Mulliqi, Anders Blilie, Xiaoyi Ji, Kelvin Szolnoky, Henrik Olsson, Matteo Titus, Geraldine Martinez Gonzalez, Sol Erika Boman, Masi Valkonen, Einar Gudlaugsson, Svein R Kjosavik, Jose Asenjo, Marcello Gambacorta, Paolo Libretti, Marcin Braun, Radzislaw Kordek, Roman Lowicki, Kristina Hotakainen, Paivi Vare, Bodil Ginnerup Pedersen, Karina Dalsgaard Sorensen, Benedicte Parm Ulhoi, Mattias Rantalainen, Pekka Ruusuvuori, Brett Delahunt, Hemamali Samaratunga, Toyonori Tsuzuki, Emilius A.M. Janssen, Lars Egevad, Kimmo Kartasalo, Martin Eklund
medRxiv 2024.07.04.24309948; doi: https://doi.org/10.1101/2024.07.04.24309948
Subject Area
Subject Areas
- Addiction Medicine (330)
- Allergy and Immunology (651)
- Anesthesia (174)
- Cardiovascular Medicine (2503)
- Dermatology (210)
- Emergency Medicine (386)
- Epidemiology (11985)
- Forensic Medicine (10)
- Gastroenterology (721)
- Genetic and Genomic Medicine (3906)
- Geriatric Medicine (365)
- Health Economics (653)
- Health Informatics (2521)
- Health Policy (973)
- Hematology (350)
- HIV/AIDS (813)
- Medical Education (386)
- Medical Ethics (106)
- Nephrology (416)
- Neurology (3661)
- Nursing (205)
- Nutrition (546)
- Oncology (1904)
- Ophthalmology (555)
- Orthopedics (230)
- Otolaryngology (299)
- Pain Medicine (243)
- Palliative Medicine (71)
- Pathology (463)
- Pediatrics (1074)
- Primary Care Research (434)
- Public and Global Health (6338)
- Radiology and Imaging (1341)
- Respiratory Medicine (846)
- Rheumatology (389)
- Sports Medicine (334)
- Surgery (426)
- Toxicology (51)
- Transplantation (179)
- Urology (156)